The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer
| Image |  |
|---|---|
| Description | article by Jong Woo Lee et al published June 2019 in Journal of Thoracic Oncology |
| Author/s |
author: Roy S. Herbst Akiko Iwasaki |
| Publication date | June 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |